Urenio Watch Watch: Intelligent Cities – Smart Cities – Innovation Ecosystems

Renegotiating Spatial Planning Practices: the role of collective initiatives and informal networks

This paper introduces an alternative narrative for urban resilience. It attempts to emphasize the value of community and its prospect to create bottom-up, non-capital oriented and non-bureaucratic urban change. In this paper, emphasis is placed on societal issues, by acknowledging the user-generated transformative power in counteracting the mundane systemic pressures, and overcoming global crises (health, economic, climate, etc.) at a local scale. Continue reading

Smart Cities in the Post-algorithmic Era: a review

The book review by Aharon Kellerman, University of Haifa, published in the special issue “Smart, sustainable and fair cities” of Geography Research Forum, vol. 40, 2020 points out:
“The concept of smart cities has become widely applied and studied as of the 1990s. However, this edited volume presents a rather fresh, challenging and even provocative
perspectives for smart cities. Continue reading

Towards High Impact Smart Cities: a Universal Architecture Based on Connected Intelligence Spaces

This paper investigates a different direction in smart city design and efficiency, based on lessons learned from high impact smart city projects and ecosystems. The authors focus on ‘˜Connected Intelligence Spaces’ created in smart city ecosystems, which (a) have physical, social, and digital dimensions; (b) work as systems of innovation enabling synergies between human, machine, and collective intelligence; and (c) improve efficiency and performance by innovating rather than optimizing city routines. Continue reading

How Industries Can Better Support Workers in a Post-Covid World

We are not yet in a post-covid world. We will get there. But it will take some time. Things are moving in the right direction. Deaths and hospitalizations are starting to decline. But new variants are more contagious than the original. One vaccine company had to stop trials in South Africa because it was not effective against that strain of the virus. The vaccines we do have are slowly finding their way into arms. However, in the U.S., that process is chaotic. Continue reading